Home/Filings/4/0000905148-25-003043
4//SEC Filing

Peterson Katharine 4

Accession 0000905148-25-003043

CIK 0001781174other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 5:19 PM ET

Size

16.3 KB

Accession

0000905148-25-003043

Insider Transaction Report

Form 4
Period: 2025-08-14
Peterson Katharine
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2025-08-14$1.39/sh99$1384,221 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1
  • filerCIK 0002022214

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:19 PM ET
Size
16.3 KB